Jeena Sikho Lifecare Limited (BOM:544476)
India · Delayed Price · Currency is INR 505.20
-1.50 (-0.30%)
At close: Aug 21, 2026
Jeena Sikho Lifecare Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 8,515 | 8,014 | 4,691 | 3,244 | 2,039 | 1,466 |
Revenue Growth | 58.77% | 70.84% | 44.59% | 59.10% | 39.13% | 7.91% |
Gross Profit Gross Profit Growth | 7,526 | 7,098 | 4,330 | 2,981 | 1,870 | 1,314 |
Operating Income Operating Income Growth | 3,093 | 3,017 | 1,167 | 881.75 | 432.25 | 149.47 |
Net Income Net Income Growth | 2,365 | 2,219 | 907.29 | 692.06 | 337.44 | 112.32 |
Earnings Per Share EPS Growth | 18.98 | 17.81 | 7.29 | 5.57 | 2.74 | 1.23 |
EPS Growth | 99.02% | 144.17% | 31.01% | 103.35% | 121.81% | 10.54% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Ayurvedic Products/Medicines Ayurvedic Products/Medicines Growth | 4,540 | 4,157 | - | - | - | - |
Ayurvedic Healthcare Services Ayurvedic Healthcare Services Growth | 3,939 | 3,834 | - | - | - | - |
Others Others Growth | - | 22.67 | - | - | - | - |
Trading of Ayurvedic Medicines and Providing Ayurvedic Therapies Trading of Ayurvedic Medicines and Providing Ayurvedic Therapies Growth | - | - | 4,691 | 3,244 | 2,039 | 1,466 |
Total Total Growth | 8,515 | 8,014 | 4,691 | 3,244 | 2,039 | 1,466 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,039 | 2,039 | 289.1 | 655.07 | 369.37 | 25.9 |
Total Debt Total Debt Growth | 1,273 | 1,273 | 107.33 | 5.4 | 8.08 | 74.35 |
Net Cash (Debt) Net Cash Growth | 766.49 | 766.49 | 181.77 | 649.68 | 361.29 | -48.45 |
Net Cash Growth | 321.68% | 321.68% | -72.02% | 79.82% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 6.15 | 6.15 | 1.46 | 5.23 | 2.93 | -0.53 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 2,538 | 686.27 | 366.89 | 171.69 | 163.54 |
Capital Expenditures CapEx Growth | - | -340.54 | -1,118 | -155.38 | -391.95 | -220.31 |
Free Cash Flow Free Cash Flow Growth | - | 2,197 | -432 | 211.51 | -220.26 | -56.77 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 88.39% | 88.58% | 92.31% | 91.90% | 91.69% | 89.63% |
Operating Margin | 36.33% | 37.65% | 24.88% | 27.18% | 21.20% | 10.20% |
Pretax Margin | 37.16% | 37.11% | 26.02% | 28.95% | 21.84% | 10.30% |
Profit Margin | 27.78% | 27.68% | 19.34% | 21.33% | 16.55% | 7.66% |
FCF Margin | - | 27.41% | -9.21% | 6.52% | -10.80% | -3.87% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 1.100 | 4.500 | 1.100 | 0.836 | 0.222 |
Dividend Per Share Growth | 0% | 309.09% | 31.58% | 276.24% | - |
Dividend Yield | 0.22% | 0.83% | - | - | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 26.56 | 30.24 | 59.81 | 30.23 | 11.86 | - |
P/FCF Ratio | 28.59 | 30.54 | - | 98.92 | - | - |
PS Ratio | 7.38 | 8.37 | 11.57 | 6.45 | 1.96 | - |